Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Immunology
  4. Role of glial 14-3-3 gamma protein in autoimmune demyelination

Role of glial 14-3-3 gamma protein in autoimmune demyelination

Journal of Neuroinflammation, 2015 · DOI: 10.1186/s12974-015-0381-x · Published: August 18, 2015

ImmunologyNeurology

Simple Explanation

This study investigates the role of 14-3-3 gamma protein in glial cells during autoimmune demyelination, a process similar to what happens in multiple sclerosis (MS). The researchers found that 14-3-3 gamma is expressed in oligodendrocytes and astrocytes, and its expression increases in the spinal cord during the chronic phase of experimental autoimmune encephalomyelitis (EAE). Mice lacking 14-3-3 gamma experienced more severe EAE, with increased myelin damage and oligodendrocyte injury, suggesting that 14-3-3 gamma plays a protective role for oligodendrocytes in neuroinflammation.

Study Duration
Not specified
Participants
Mice (14-3-3 γ knockout mice and C57BL/6 control mice)
Evidence Level
Not specified

Key Findings

  • 1
    14-3-3 γ mRNA expression increases in the spinal cord during the late chronic phase of MOG-EAE.
  • 2
    14-3-3 γ knockout mice subjected to MOG-EAE exhibit more severe disease compared to controls, particularly in the chronic phase.
  • 3
    Histopathological analyses reveal enhanced myelin damage, oligodendrocyte injury, increased axonal injury, and gliosis in 14-3-3 γ knockout mice during chronic EAE.

Research Summary

This study investigates the role of 14-3-3 γ in glial cells during autoimmune demyelination using a knockout mouse model of EAE. The findings indicate that 14-3-3 γ is expressed in oligodendrocytes and astrocytes and its expression increases during the chronic phase of EAE. 14-3-3 γ deficiency leads to more severe EAE with enhanced demyelination, oligodendrocyte loss, and increased oligodendrocyte apoptosis, suggesting a protective role for 14-3-3 γ in autoimmune demyelination.

Practical Implications

Therapeutic Target

14-3-3 γ protein may represent a therapeutic target for protecting oligodendrocytes in MS.

Biomarker Potential

CSF levels of 14-3-3 γ could potentially serve as a biomarker for assessing myelin damage in MS.

Understanding MS Pathology

Further understanding the role of 14-3-3 γ in glial cells may provide insights into mechanisms of tissue destruction in MS.

Study Limitations

  • 1
    The study is limited to a murine model of EAE, and findings may not directly translate to human MS.
  • 2
    The study focuses primarily on 14-3-3 γ and does not fully explore the roles of other 14-3-3 isoforms.
  • 3
    The mechanisms by which 14-3-3 γ protects oligodendrocytes from apoptosis are not fully elucidated.

Your Feedback

Was this summary helpful?

Back to Immunology